Baker Bros. Advisors »

Maplight Therapeutics shares owned by Baker Bros. Advisors

Quarter-by-quarter ownership of Maplight Therapeutics (MPLT) shares owned by Baker Bros. Advisors from 13F filings

Historical chart of Baker Bros. Advisors investment in Maplight Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Maplight Therapeutics held by Baker Bros. Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maplight Therapeutics by Baker Bros. Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $6.4M 365k 17.57

More positions owned by Baker Bros. Advisors

Incyte Corporation (INCY)
BeOne Medicines Sponsored Ads (ONC)
Madrigal Pharmaceuticals (MDGL)
Insmed Incorporated Com Par $.01 (INSM)
ACADIA Pharmaceuticals (ACAD)
Celcuity (CELC)
Revolution Medicines (RVMD)
Kymera Therapeutics (KYMR)
Summit Therapeutics (SMMT)
Rhythm Pharmaceuticals (RYTM)
Kodiak Sciences (KOD)
Praxis Precision Medicines I (PRAX)
Alkermes SHS (ALKS)
Grail (GRAL)
Edgewise Therapeutics (EWTX)

View all positions for Baker Bros. Advisors

Top funds holding Maplight Therapeutics

Novo A/S
Fcpm Iii Services B.v.
T. Rowe Price Investment Management
Goldman Sachs Group
BlackRock
Nan Fung Group Holdings
5AM Venture Management
Sanofi
Vanguard Group
Pivotal bioVenture Partners Investment Advisor
Perceptive Advisors
Velan Capital Investment Management
Siren
Geode Capital Management
Vestal Point Capital

View all funds holding Maplight Therapeutics